They have FDA clearance, rather than FDA approval I believe.
This is what Bing says when I asked what the difference between FDA clearance and FDA approval was:
"FDA approval and FDA clearance are two different regulatory processes that the FDA uses to evaluate medical devices and drugs. FDA approval is a higher standard because the safety and effectiveness of the specific product has been tested1. The FDA approves drugs, while it clears medical devices2. FDA clearance is a lower standard, and in many cases, the product is cleared because it is similar to an existing product rather than that it has passed rigorous independent safety trials."
this company management track records are extremely bad!
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-2387
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $14.70M |
Open | High | Low | Value | Volume |
2.0¢ | 2.3¢ | 2.0¢ | $1.21K | 55.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 152314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 314348 | 0.020 |
5 | 604260 | 0.019 |
9 | 1162558 | 0.018 |
3 | 410000 | 0.017 |
1 | 62561 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 99683 | 1 |
0.024 | 631111 | 3 |
0.025 | 459000 | 2 |
0.026 | 1590045 | 4 |
0.027 | 683000 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AT1 (ASX) Chart |